City Center Advisors, LLC Adma Biologics, Inc. Transaction History
City Center Advisors, LLC
- $93.3 Billion
- Q2 2025
A detailed history of City Center Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, City Center Advisors, LLC holds 10,597 shares of ADMA stock, worth $189,474. This represents 0.21% of its overall portfolio holdings.
Number of Shares
10,597Holding current value
$189,474% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
382Shares Held
187MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$333 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$301 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$230 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$205 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$101 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.51B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...